SHTDF
Price
$2.16
Change
-$0.02 (-0.92%)
Updated
Jun 30 closing price
Capitalization
9.79B
ZYXI
Price
$2.40
Change
-$0.29 (-10.78%)
Updated
Jul 3 closing price
Capitalization
397.95M
19 days until earnings call
Interact to see
Advertisement

SHTDF vs ZYXI

Header iconSHTDF vs ZYXI Comparison
Open Charts SHTDF vs ZYXIBanner chart's image
Sinopharm Group
Price$2.16
Change-$0.02 (-0.92%)
Volume$200
Capitalization9.79B
Zynex
Price$2.40
Change-$0.29 (-10.78%)
Volume$243.22K
Capitalization397.95M
SHTDF vs ZYXI Comparison Chart in %
Loading...
SHTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYXI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SHTDF vs. ZYXI commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SHTDF is a Hold and ZYXI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (SHTDF: $2.16 vs. ZYXI: $2.40)
Brand notoriety: SHTDF and ZYXI are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: SHTDF: 7% vs. ZYXI: 99%
Market capitalization -- SHTDF: $9.79B vs. ZYXI: $397.95M
SHTDF [@Medical Distributors] is valued at $9.79B. ZYXI’s [@Medical Distributors] market capitalization is $397.95M. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SHTDF’s FA Score shows that 1 FA rating(s) are green whileZYXI’s FA Score has 0 green FA rating(s).

  • SHTDF’s FA Score: 1 green, 4 red.
  • ZYXI’s FA Score: 0 green, 5 red.
According to our system of comparison, SHTDF is a better buy in the long-term than ZYXI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SHTDF’s TA Score shows that 1 TA indicator(s) are bullish while ZYXI’s TA Score has 5 bullish TA indicator(s).

  • SHTDF’s TA Score: 1 bullish, 3 bearish.
  • ZYXI’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ZYXI is a better buy in the short-term than SHTDF.

Price Growth

SHTDF (@Medical Distributors) experienced а -1.03% price change this week, while ZYXI (@Medical Distributors) price change was -8.05% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +2.01%. For the same industry, the average monthly price growth was +7.79%, and the average quarterly price growth was -2.46%.

Reported Earning Dates

ZYXI is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Medical Distributors (+2.01% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHTDF($9.79B) has a higher market cap than ZYXI($398M). ZYXI has higher P/E ratio than SHTDF: ZYXI (46.30) vs SHTDF (8.00). SHTDF YTD gains are higher at: -13.253 vs. ZYXI (-70.037). SHTDF has higher annual earnings (EBITDA): 24.7B vs. ZYXI (17.9M). SHTDF has more cash in the bank: 43.5B vs. ZYXI (44.6M). ZYXI has less debt than SHTDF: ZYXI (76.2M) vs SHTDF (68.4B). SHTDF has higher revenues than ZYXI: SHTDF (521B) vs ZYXI (184M).
SHTDFZYXISHTDF / ZYXI
Capitalization9.79B398M2,459%
EBITDA24.7B17.9M137,989%
Gain YTD-13.253-70.03719%
P/E Ratio8.0046.3017%
Revenue521B184M283,152%
Total Cash43.5B44.6M97,534%
Total Debt68.4B76.2M89,764%
FUNDAMENTALS RATINGS
SHTDF vs ZYXI: Fundamental Ratings
SHTDF
ZYXI
OUTLOOK RATING
1..100
506
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
93
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5795
PRICE GROWTH RATING
1..100
6264
P/E GROWTH RATING
1..100
5693
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SHTDF's Valuation (21) in the null industry is significantly better than the same rating for ZYXI (93) in the Medical Specialties industry. This means that SHTDF’s stock grew significantly faster than ZYXI’s over the last 12 months.

SHTDF's Profit vs Risk Rating (100) in the null industry is in the same range as ZYXI (100) in the Medical Specialties industry. This means that SHTDF’s stock grew similarly to ZYXI’s over the last 12 months.

SHTDF's SMR Rating (57) in the null industry is somewhat better than the same rating for ZYXI (95) in the Medical Specialties industry. This means that SHTDF’s stock grew somewhat faster than ZYXI’s over the last 12 months.

SHTDF's Price Growth Rating (62) in the null industry is in the same range as ZYXI (64) in the Medical Specialties industry. This means that SHTDF’s stock grew similarly to ZYXI’s over the last 12 months.

SHTDF's P/E Growth Rating (56) in the null industry is somewhat better than the same rating for ZYXI (93) in the Medical Specialties industry. This means that SHTDF’s stock grew somewhat faster than ZYXI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SHTDFZYXI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bearish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
60%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 3 days ago
64%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
SHTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYXI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FNLIF27.63N/A
N/A
First National Financial Corp.
PIAIF5.97N/A
N/A
Ping An Insurance (Group) Company of China Ltd.
UNBLF95.46N/A
N/A
Unibail-Rodamco SE
IARGF12.00N/A
N/A
I A R Systems Group AB
FXLV0.07-0.01
-9.91%
F45 Training Holdings Inc.

SHTDF and

Correlation & Price change

A.I.dvisor tells us that SHTDF and SHTDY have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHTDF and SHTDY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHTDF
1D Price
Change %
SHTDF100%
N/A
SHTDY - SHTDF
17%
Poorly correlated
+0.35%
ZYXI - SHTDF
9%
Poorly correlated
-10.78%
NSVGF - SHTDF
4%
Poorly correlated
N/A
SHPMY - SHTDF
3%
Poorly correlated
N/A
COSM - SHTDF
2%
Poorly correlated
+1.83%
More

ZYXI and

Correlation & Price change

A.I.dvisor tells us that ZYXI and HSIC have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZYXI and HSIC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZYXI
1D Price
Change %
ZYXI100%
-10.78%
HSIC - ZYXI
24%
Poorly correlated
+0.26%
OMI - ZYXI
17%
Poorly correlated
-0.86%
SHTDF - ZYXI
9%
Poorly correlated
N/A
YI - ZYXI
9%
Poorly correlated
+1.23%
EDAP - ZYXI
8%
Poorly correlated
+1.27%
More